The evaluation and treatment of depression in primary care

Clinical Cornerstone

Volumn 3, Issue 3, 2001, Pages 10-20

  Compton, Michael T ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMFEBUTAMONE; AMITRIPTYLINE; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CLOMIPRAMINE; CLONIDINE; CORTICOSTEROID; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; GUANETHIDINE; IMIPRAMINE; ISOCARBOXAZID; ISOTRETINOIN; METHYLDOPA; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; RESERPINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ANEMIA; ANORGASMIA; ARTICLE; BEHAVIOR; COGNITION; CONTROLLED RELEASE FORMULATION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISABILITY; DRUG COST; DRUG OVERDOSE; EJACULATION; ELECTROCONVULSIVE THERAPY; EMOTION; ENDOCRINE DISEASE; EVALUATION; GENERAL PRACTICE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; HYPOXIA; KIDNEY FAILURE; LIBIDO; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; NEUROLOGIC DISEASE; PATIENT EDUCATION; PREVALENCE; PRIMARY MEDICAL CARE; PSYCHOSIS; PSYCHOSOCIAL DISORDER; PSYCHOTHERAPY; RATING SCALE; RECURRENT DISEASE; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN DEFICIENCY;

EID: 0035041459     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(01)90058-4     Document Type: Article

References (21)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
2. Hirschfeld RM, Montgomery SA, Keller MB, et al. Social functioning in depression: a review. J Clin Psychiatry. 2000;61:268-275.
3. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580-592.
4. Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life. Consensus statement update. JAMA. 1997;278: 1186-1190.
5. Fredman SJ, Rosenbaum JF. Recurrent depression, resistant clinician? Harv Rev Psychiatry. 1998;5: 281-285.
6. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 1997;277:333-340.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
8. Bhatia SC, Bhatia SK. Major depression: selecting safe and effective treatment. Am Fam Phys. 1997; 55:1683-1698.
9. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
10. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
11. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder (Revision). Washington, DC: American Psychiatric Association; 2000.
12. Linden M, Gothe H, Dittmann RW, Schaaf B. Early termination of antidepressant drug treatment. J Clin Psychopharmacol. 2000;20:523-530.
13. Kupfer DJ, Frank E, Perel JM, et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1992;49:769-773.
14. Owens MJ. Molecular and cellular mechanisms of antidepressant drugs. Depression Anxiety. 1997;4: 153-159.
15. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry. 1996;153:311-320.
16. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol. 1996;16:356-362.
17. Compton MT, Nemeroff CB. The treatment of bipolar depression. J Clin Psychiatry. 2000;61(suppl 9):57-67.
18. Nemeroff CB. Augmentation strategies in patients with refractory depression. Depression Anxiety. 1997;4:169-181.
19. Reynolds CF III, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA. 1999;281:39-45.
20. Wheeler Vega JA, Mortimer AM, Tyson PJ. Somatic treatment of psychotic depression: review and recommendations for practice. J Clin Psychopharmacol. 2000;20:504-519.
21. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48: 851-855.